Elizabeth M. Greetham

This profile gathers the share dealings of Elizabeth M. Greetham across 2 companies, led by King Pharmaceuticals Inc and Ligand Pharmaceuticals Inc. Over a trading history stretching from 28 April 2006 to 31 January 2011, the count stands at 10 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The newest entry dates from 2 February 2011: a transaction, in King Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.